With less than a month to go until the annual rendezvous of creativity, medicine and technology that is TEDMED, the event’s organizers have revealed the final list of presenters, and it’s loaded with familiar faces.
In its third year under Priceline.com founder Jay Walker, TEDMED is shaping up this year much like in years past – focused on hot-button topics with a touch of heart. The agenda features talks from dancers, photographers, musicians and artists. But it will also put some of healthcare’s buzzworthy topics center stage — like big data, patient empowerment and encouraging innovation.
Here are a few familiar faces we’ll be watching for.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Harvey Fineberg, “What is the U.S. health disadvantage?” As the president of the Institute of Medicine and past dean of the Harvard School of Public Health, Fineberg is a wealth of knowledge on health policy and innovation.
Ryan Panchadsaram, “How do we move from health data to health dialog?” Before becoming a Presidential Innovation Fellow, Panchadsaram co-founded mobile health startup Pipette, which went through Rock Health’s first accelerator class and was snatched up by Ginger.io in 2012.
Roni Zeiger, “Who is the real medical expert?” This physician left behind his role as chief health strategist for Google to start the patient community Smart Patients.
Laura Deming, “How do we make prevention a $1 trillion business?” She’s an 18-year-old venture capitalist and Thiel Fellow who’s fascinated with longevity and anti-aging technology. That in itself is fascinating.
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Steve Gullans, “When is ‘safe dosing’ a dangerous prescription?” Gullans is an entrepreneur, scientist and investor at Excel Ventures who’s also a former faculty member at Harvard Medical School and Brigham and Women’s Hospital. He sits on the boards of a number of life science companies including Cleveland HeartLab.
Jonathan Bush, “For profit & non-profits: Can this marriage be saved?” Everyone’s favorite loquacious CEO will talk on the challenges of aligning interests in healthcare.
Deborah Estrin, “What happens when each patient becomes their own ‘universe’ of unique medical data?” Estrin is a professor computer science and co-founder of the non-profit startup Open mHealth, which is building an open software platform to encourage collaboration among mHealth developers.
Check out the full agenda here. Which talks are you most eager to see?
